1. Home
  2. LI vs HOLX Comparison

LI vs HOLX Comparison

Compare LI & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Li Auto Inc.

LI

Li Auto Inc.

HOLD

Current Price

$16.05

Market Cap

19.1B

ML Signal

HOLD

Logo Hologic Inc.

HOLX

Hologic Inc.

HOLD

Current Price

$76.02

Market Cap

16.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LI
HOLX
Founded
2015
1985
Country
China
United States
Employees
30728
N/A
Industry
Auto Manufacturing
Medical Electronics
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.1B
16.9B
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
LI
HOLX
Price
$16.05
$76.02
Analyst Decision
Hold
Hold
Analyst Count
10
13
Target Price
$19.66
$77.89
AVG Volume (30 Days)
3.0M
95.4M
Earning Date
05-28-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.79
Revenue
N/A
$4,100,500,000.00
Revenue This Year
$18.98
$4.74
Revenue Next Year
$22.72
$5.03
P/E Ratio
$29.50
$96.23
Revenue Growth
N/A
1.74
52 Week Low
$15.71
$53.62
52 Week High
$32.03
$76.07

Technical Indicators

Market Signals
Indicator
LI
HOLX
Relative Strength Index (RSI) 34.77 69.09
Support Level N/A $75.10
Resistance Level $19.04 N/A
Average True Range (ATR) 0.49 0.19
MACD -0.17 0.03
Stochastic Oscillator 4.71 95.19

Price Performance

Historical Comparison
LI
HOLX

About LI Li Auto Inc.

Li Auto is a leading Chinese NEV manufacturer that designs, develops, manufactures, and sells premium smart NEVs. The company started volume production of its first model Li One in November 2019. The model is a six-seater, large, premium plug-in electric SUV equipped with a range extension system and advanced smart vehicle solutions. It sold over 400,000 NEVs in 2025, accounting for about 3% of China's passenger new energy vehicle market. Beyond Li One, the company expands its product line, including both BEVs and PHEVs, to target a broader consumer base.

About HOLX Hologic Inc.

Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.

Share on Social Networks: